Mode
Text Size
Log in / Sign up
N/A N=44

Swallowing Impairment After COVID-19 Infection

Covid19

Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcome: Primary: Number of Participants With Impaired Swallowing Safety — 3; 1 Participants — p=<0.001

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Videofluoroscopic Swallowing Study (VFSS) (Diagnostic_test)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University Health Network, Toronto
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Impaired Swallowing Safety
3; 1 <0.001 sig
PRIMARY
Number of Participants With Impaired Swallowing Efficiency
4; 0 <0.001 sig
SECONDARY
Number of Participants With Prolonged Time-to-Laryngeal-Vestibule-Closure
6; 14
SECONDARY
Number of Participants With Short Laryngeal Vestibule Closure Duration
3; 4
SECONDARY
Number of Participants With Poor Pharyngeal Constriction
6; 6
SECONDARY
Number of Participants With Impaired LVC Integrity
1; 0

Summary

This is an observational study, in which people recovering from COVID-19 infection will attend an outpatient clinic for a comprehensive swallowing assessment. The assessment will include a videofluoroscopy, measurement of respiratory-swallow coordination using a digital stethoscope, measures of tongue and cough strength and patient reported measures that will help us to understand the presence and impact of swallowing impairment (dysphagia) in this population.

Eligibility Criteria

Inclusion Criteria

  • People who tested positive or received a presumed positive diagnosis of COVID-19 infection not earlier than March 1, 2020 and who are at least 2 weeks post positive diagnosis and the initiation of medical management of COVID-19 infection
  • Adequate comprehension of English to understand the consent form and follow study instructions

Exclusion Criteria

  • Age under 18 years old
  • Current pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04537650). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search